
Discovering novel antimalarials to block parasite invasion of human cells
Drugs are the main weapons used to combat malaria infection, but parasites are becoming resistant and new medicines and drug targets are needed. We are developing new antimalarials that prevent the parasite from entering the host red blood cell. If the parasite cannot invade, it cannot cause disease. We use our extensive history in deciphering the invasion process of malaria parasites to inform drug discovery.
Objective
We seek to better understand how the malaria parasite enters red blood cells, and to use this knowledge to discover and develop novel therapeutics.
Timeline
2003–ongoing.
Approach
We are pioneers in using live cell microscopy to investigate how malaria parasites get into host red blood cells. We use this specialised technique to aid in our discovery of novel antimalarial compounds that inhibit this process.
Community impact
Better, safer and cheaper antimalarial drugs would benefit endemic communities around the world and could accelerate malaria elimination. The research will also provide new knowledge about parasite biology that could inform future treatment options.
Partners
Funding partners
- National Health and Medical Research Council (NHMRC)
Collaborators
- WEHI (Brad Sleebs, William Nguyen, Madeline Dans)
- Deakin University/Burnet Institute (Alyssa Barry)
- Deakin University (Tania de Koning-Ward)
- Monash University (Darren Creek, Ghizal Siddiqui)
Project contacts

Associate Professor Paul Gilson
Deputy Discipline Head, Life Sciences; Co-Head Malaria Virulence, Drug Discovery and Resistance; Head of Burnet Cell Imaging Facility
Project team

Associate Professor Paul Gilson
Deputy Discipline Head, Life Sciences; Co-Head Malaria Virulence, Drug Discovery and Resistance; Head of Burnet Cell Imaging Facility

Claudia Barnes
Research Assistant

Dr Hayley Bullen
Co-Head Malaria Virulence, Drug Discovery and Resistance

Professor Brendan Crabb AC
Director and CEO; Chair Australian Global Health Alliance and Chair Pacific Friends of Global Health

Alysha Literski
PhD student
